{"SPADE_N_05990": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_05990", "Peptide Name": "AMPR-11(derived from Romo1)", "Source": "Homo sapiens (Human)", "Family": "Belongs to the MGR2 family.", "Gene": "ROMO1", "Sequence": "KTMMQSGGTFGTFMAIGMGIR", "Sequence Length": 21, "UniProt Entry": ["http://www.uniprot.org/uniprot/P60602"], "Protein Existence": "Protein level", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram-", "Anti-Gram+"], "Target Organism": "[Ref.33291307] Gram-positive bacteria:S. aureus(MBC=100 μg/mL), B. subtilis(MBC=90 μg/mL), E. faecium(MBC=85 μg/mL), S. sindenensis(MBC=95 μg/mL), E. faecalis(MBC=85 μg/mL), S. pneumoniae(MBC=100 μg/mL)Gram-negative bacteria:E. coli(MBC=85 μg/mL), P. aeruginosa(MBC=100 μg/mL), K. pneumoniae(MBC=100 μg/mL), A. baumannii(MBC=100 μg/mL), E. aerogenes(MBC=90 μg/mL)Multi-drug resistant bacteria:Methicillin-resistant S. aureus(MBC=100 μg/mL), Carbapenem-resistant P. aeruginosa(MBC=110 μg/mL), Carbapenem-resistant A. baumannii(MBC=110 μg/mL), Carbapenem-resistant K. pneumoniae(MBC=100 μg/mL), Vancomycin-resistant S. aureus(MBC=120 μg/mL), Vancomycin-resistant E. faecium(MBC=100 μg/mL )", "Hemolytic Activity": "[Ref.33291307]At the concentration of 32 μg/mL, AMPR-11 induced a hemolysis of 20% on mouse red blood cells; At the concentration of 256 μg/mL, AMPR-11 induced a hemolysis of 23%.", "Cytotoxicity": "[Ref.33291307] ①The cell viability of HeLa cells was 90%, 87%, 83% and 79% at the concentration of 32, 64, 128 and 256 μg/mL. ②The cell viability of HEK293 cells was 86%, 83%, 80% and 78% at the concentration of 32, 64, 128 and 256 μg/mL. ③The cell viability of HeLa cells was 89%, 86%, 83% and 80% at the concentration of 32, 64, 128 and 256 μg/mL.", "Binding Target": "Bacterial membrane", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "AMPR-11 formed a random coil structure in distilled water but formed an ordered conformation in 50% hexafluoro-2-propanol (HFIP), which has been used for implementing a membrane-mimic environment", "Formula": "C95H156N26O27S4", "Mass": 2222.67, "PI": 11.0, "Net Charge": 2, "Hydrophobicity": 0.34, "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min", "Comments": "AMP derived from Romo1 (AMPR-11) is a promising agent for treatment of sepsis caused by MDR bacteria, and AMPR-11 could be combined with other potential antibiotics for clinical treatment.", "Literature": [{"Title": "Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent against Multidrug-Resistant Bacteria in a Murine Model of Sepsis", "Pubmed ID": "32291307", "Reference": "mBio. 2020 Apr 14;11(2)e03258-19. doi 10.1128/mBio.03258-19.", "Author": "Lee HR, You DG, Kim HK, Sohn JW, Kim MJ, Park JK, Lee GY, Yoo YD", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=32291307"}], "Frequent Amino Acids": "GMT", "Absent Amino Acids": "CDEHLNOPUVWY", "Basic Residues": 2, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 8, "Positive Residues": 2, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_01892", "Similarity": 1.0, "Sequence": "MPVAVGPYGQSQPSCFDRVKMGFMMGFAVGMAAGALFGTFSCLRFGMRGRELMGGVGKTMMQSGGTFGTFMAIGMGIRC"}, {"SPADE_ID": "SPADE_N_01995", "Similarity": 1.0, "Sequence": "MPVAVGPYGQSQPNCFDRVKMGFMMGFAVGMAAGALFGTFSCLRFGMRGRELMGGVGKTMMQSGGTFGTFMAIGMGIRC"}, {"SPADE_ID": "SPADE_N_02082", "Similarity": 1.0, "Sequence": "MPVSVGSYGQQAQPSCFDRVKMGFMMGFAVGMAAGAMFGTFSCLRIGMRGRELMGGVGKTMMQSGGTFGTFMAIGMGIRC"}]}}}